FDA Approves New Treatment for a Type of Late-stage Lung Cancer
The U.S. Food and Drug Administration has approved Gilotrif (afatinib) for patients with late stage (metastatic) non-small cell lung cancer (NSCLC) whose tumors express specific types of epidermal epidermal growth factor receptor (EGFR) gene mutations, as detected by an FDA-approved test.
Set the Stage for a Smoke-Free Life
by Amanda Palmer, BA, and Benjamin Toll, PhD
Many people with cancer who smoke feel it is too late to quit smoking. The truth is it’s never too late to quit. And quitting smoking may actually improve the effectiveness of your treatments while helping you live a healthier life.
Non-Small Cell Lung Cancer
Different types of treatments are available for people with non-small cell lung cancer. Surgery, radiation therapy, chemotherapy, targeted therapy, laser therapy, photodynamic therapy, cryosurgery, electrocautery, and watchful waiting are the nine standard treatments used for this cancer.
Steps to Help You Stop Smoking for Good
by Thomas H. Brandon, PhD, and Vani Nath Simmons, PhD
After receiving a cancer diagnosis, some people feel that there is no longer any point to quitting smoking, that it is now too late. However, it is never too late to quit smoking. Indeed, quitting smoking can be especially important for cancer survivors.
American Lung Association Resource Offers Lung Cancer Patients and Caregivers
The American Lung Association has launched Facing Lung Cancer: Support from Day One, a new patient- and caregiver-focused, web-based lung cancer information resource. This online tool offers interactive features that address specific topics of interest for people living with lung cancer and their loved ones.
Patient Advocate Foundation Receives Support to Aid Lung Cancer Survivors through Its Co-Pay Relief Program
The Patient Advocate Foundation has received a generous contribution that will allow the Foundation to continue to support people with non-squamous non-small cell lung cancer within its Co-Pay Relief Program. The program provides direct financial support for pharmaceutical co-payments to insured patients, including Medicare Part D beneficiaries, who financially and medically qualify, significantly reducing the financial burden associated with high medication costs.
Health and Prognosis Not Taken Into Account When Treating Older People with Lung Cancer
The study, published in the Journal of Clinical Oncology, found that treatment rates decreased more in association with advancing age than with the worsening of other illnesses. People between the ages of 65 and 74 who were severely ill from other illnesses, and thus less likely to benefit and more likely to be harmed from cancer treatment, received treatment at roughly the same rate as those in the same age range with no comorbidities.
Seven Tips to Successfully Quit Smoking in the New Year
This holiday season, countless Americans will make the New Year’s resolution to quit smoking in 2012. While quitting smoking is extremely difficult—six out of 10 smokers require multiple quit attempts to stop smoking—preparing a quit-smoking plan can greatly improve a person's chance for success. The following are proven tips and resources from the American Lung Association that have helped thousands of people give up smoking for good.